Peter Beck has a bold plan to turn Rocket Lab into a self-launching Tier 1 space power, but hitting the price target that would prove him right requires several high-stakes moves to land just right.
Rocket Lab (NASDAQ: RKLB | RKLB Price Prediction) has built a history of building and flying rockets. Its founder and CEO, Peter Beck, now wants to play a much bigger role. When he announced the Iridium Communications (NASDAQ:IRDM), Beck said the deal makes Rocket Lab “a self-launching Tier 1 space power that will provide critical communications capabilities to millions of users around the world.” Iridium shareholders approved the deal in September.
The stock has lagged behind the company. Shares are down 2.22% year-to-date at $68.21, even though second-quarter revenue rose 62% to a record. Several things need to happen for Rocket Lab to reach $125 per share in 2027.
Wall Street already sees a 56% increase
The average analyst target is $106.57, implying a 56% upside. Ratings stand at 4 strong buy, 12 buy, 4 hold and zero sell. Rocket Lab has exceeded revenue estimates in each of the last 4 quarters. Second-quarter EPS of -$0.08 missed the estimate of -$0.0767, but that figure included $8.58 million in acquisition costs. Backlog reached $2.36 billion, up 137%, and revenue guidance for the third quarter is in the range of $250 million to $265 million.
Here’s what it takes to reach $125
Rocket Lab is not yet profitable, so price-to-sales is the best measure. Shares trade at 56.7x trailing sales. At $125, this multiple would rise to approximately 104x. That’s a significant premium, but it’s close to the 93 times investors pay EspaceX (NASDAQ:SPCX). SpaceX reported $7.81 billion in revenue in the second quarter, of which $648 million came from launch services. The launch alone is a significant market.
How Rocket Lab could reach $125.
- The beginnings of Neutron: Neutron is Rocket Lab’s reusable medium-range rocket, and its starting price of $50 million to $55 million puts it in competition with Falcon 9. CNBC reported that management expects the boosters to fly 10 to 20 times each. Beck put it bluntly: “The demand for neutrons is simply not a problem. »
- Defense spending: The FY 2027 budget includes $17.9 billion for Golden Dome. Rocket Lab already has an $816 million contract with the Space Development Agency and a Flatellite award of $397 million.
- Iridium: Iridium has generated more than $870 million in annual revenue and the deal is expected to close in mid-2027.
- Margin gains: Non-GAAP gross margin increased from 36.9% to 41.5%. The adjusted EBITDA loss fell from $27.6 million to $8.8 million.
The Neutron launch can change the dynamic and make Rocket Lab a viable challenger to SpaceX. With the cost per launch expected to drop from around $130 million to $50 million as volume increases, this would make Rocket Lab a cost-effective alternative to its rival.
Key risks: Neutron’s first year-end launch window is narrowing and Rocket Lab raised $1.53 billion by selling shares in the first half of 2026, diluting existing shareholders.
Stocks have topped $125 over the past year
Reaching $125 requires a gain of 83%. The stock is already trading above that level: its 52-week range is $37.57 to $151, a change of about 302%. With a beta of 2,938, Rocket Lab will likely scale far more than the overall market. Over five years, shares have gained 363.7%.
$125 is over the top, but within reach
Reaching $125 would represent an 83% gain in 2027. Analysts already see 56% upside potential, the delay continues to hit records and Neutron could begin to compete directly with SpaceX. Execution risk is real. Still, returns at this level are unlikely every year, and this is the model under which Rocket Lab could generate outsized returns in 2027.
Contact (email protected) for any questions or corrections.
Gn bussni
